Acute Kidney Injury in Patients on SGLT2 Inhibitors: A Propensity-Matched Analysis

OBJECTIVE: Sodium-glucose cotransporter-2 (SGLT2) inhibitors are new medications that improve cardiovascular and renal outcomes in patients with type 2 diabetes (T2D). However, the Food and Drug Administration has issued alerts regarding increased acute kidney injury (AKI) risk with canagliflozin an...

Descripción completa

Detalles Bibliográficos
Autores principales: Nadkarni, Girish N., Ferrandino, Rocco, Chang, Alexander, Surapaneni, Aditya, Chauhan, Kinsuk, Poojary, Priti, Saha, Aparna, Ferket, Bart, Grams, Morgan E., Coca, Steven G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2017
Materias:
Epidemiology/Health Services Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652593/
https://www.ncbi.nlm.nih.gov/pubmed/28827404
http://dx.doi.org/10.2337/dc17-1011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652593/
https://www.ncbi.nlm.nih.gov/pubmed/28827404
http://dx.doi.org/10.2337/dc17-1011

Ejemplares similares